Shanghai Institute Materia Medica; Chinese Academy Of Sciences
发明人:
申请号：
EP11847845.2
公开号：
EP2649999A1
申请日:
2011.12.02
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
Disclosed is a use of a quinazoline compound of Formula I having 2,4-diaminoquinazoline as a parent nucleus in preparation of a medicament for treating diseases caused by flaviviridae infection, especially a use in combating Hepatitis C virus infection and Dengue fever virus infection.
